» Articles » PMID: 19003912

Cell Culture-produced Hepatitis C Virus Does Not Infect Peripheral Blood Mononuclear Cells

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2008 Nov 13
PMID 19003912
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Hepatitis C virus (HCV) replicates primarily in the liver, but HCV RNA has been observed in association with other tissues and cells including B and T lymphocytes, monocytes, and dendritic cells. We have taken advantage of a recently described, robust system that fully recapitulates HCV entry, replication and virus production in vitro to re-examine the issue of HCV infection of blood cell subsets. The HCV replicase inhibitor 2'C-methyl adenosine was used to distinguish HCV RNA replication from RNA persistence. Whereas cell culture-grown HCV replicated in Huh-7.5 hepatoma cells, no HCV replication was detected in B or T lymphocytes, monocytes, macrophages, or dendritic cells from healthy donors. No blood cell subset tested expressed significant levels of Claudin-1, a tight junction protein needed for HCV infection of Huh-7.5 cells. A B cell line expressing high levels of Claudin-1, CD81, and scavenger receptor BI remained resistant to HCV pseudoparticle infection. We bypassed the block in HCV entry by transfecting HCV RNA into blood cell subsets. Transfected RNA was not detectably translated and induced high levels of interferon-alpha. Supernatants from HCV RNA-transfected macrophages inhibited HCV replication in Huh-7.5 cells.

Conclusion: We conclude that multiple blocks prevent blood cells from supporting HCV infection.

Citing Articles

Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.

Frericks N, Brown R, Reinecke B, Herrmann M, Bruggemann Y, Todt D J Virol. 2024; 98(3):e0192123.

PMID: 38319104 PMC: 10949430. DOI: 10.1128/jvi.01921-23.


Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells.

Liu C, Tai C, Kuo Y, Chang S, Lin L Viruses. 2023; 15(6).

PMID: 37376594 PMC: 10302104. DOI: 10.3390/v15061294.


Fitness-Dependent, Mild Mutagenic Activity of Sofosbuvir for Hepatitis C Virus.

Martinez-Gonzalez B, Gallego I, Gregori J, Soria M, Somovilla P, de Avila A Antimicrob Agents Chemother. 2023; 67(7):e0039423.

PMID: 37367486 PMC: 10353389. DOI: 10.1128/aac.00394-23.


Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus.

Liu D, Ndongwe T, Ji J, Huber A, Michailidis E, Rice C Viruses. 2023; 15(4).

PMID: 37112961 PMC: 10143304. DOI: 10.3390/v15040981.


Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells.

Garcia-Crespo C, Francisco-Recuero I, Gallego I, Camblor-Murube M, Soria M, Lopez-Lopez A Front Cell Infect Microbiol. 2023; 13:1057082.

PMID: 36992689 PMC: 10040758. DOI: 10.3389/fcimb.2023.1057082.


References
1.
MacParland S, Pham T, Gujar S, Michalak T . De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro. J Gen Virol. 2006; 87(Pt 12):3577-3586. DOI: 10.1099/vir.0.81868-0. View

2.
Barth H, Liang T, Baumert T . Hepatitis C virus entry: molecular biology and clinical implications. Hepatology. 2006; 44(3):527-35. DOI: 10.1002/hep.21321. View

3.
Grove J, Huby T, Stamataki Z, Vanwolleghem T, Meuleman P, Farquhar M . Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Virol. 2007; 81(7):3162-9. PMC: 1866051. DOI: 10.1128/JVI.02356-06. View

4.
Scarselli E, Ansuini H, Cerino R, Roccasecca R, Acali S, Filocamo G . The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002; 21(19):5017-25. PMC: 129051. DOI: 10.1093/emboj/cdf529. View

5.
Lerat H, Berby F, Trabaud M, Vidalin O, Major M, Trepo C . Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest. 1996; 97(3):845-51. PMC: 507124. DOI: 10.1172/JCI118485. View